REMEDI
REMEDI is a South Korean medical device company that designs ultra-compact portable X-ray systems for point-of-care use, serving government health programs, defense agencies, and hospitals across 58 countries with 10,000+ units deployed.
- Company typePrivate
- Founded2012
- HeadquartersYongdungpo, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What REMEDI does
REMEDI is a South Korean medical device company founded in 2012 that designs, manufactures, and distributes ultra-compact, portable digital X-ray systems for point-of-care use. Its product line consists of seven portable X-ray devices built around proprietary X-ray tube technology, with global regulatory clearances including FDA, CE, KFDA, and Japan's PMDA. The company has cumulatively shipped more than 10,000 units across 58 countries, anchored by relationships with institutions such as NASA, JICA, and India's National Tuberculosis Elimination Program, which ordered 1,534 units in September 2025. REMEDI is also developing the next-generation XCam10 device and the Rena'ssant AI imaging platform, while pursuing partnerships with JLK for lung diagnostics, Data4Life for a global TB imaging data platform, and Hippocrates Labs for clinical summarization, signaling an evolution from pure hardware sales toward AI-enabled, software-attached offerings.
The company operates a hybrid distribution model with 96 overseas distributors and 86 domestic partners, complemented by direct institutional sales to government health programs and space agencies. Leadership is centered on founder and CEO Choi Joon-ho, who holds an MIT PhD in radiation engineering with 30+ years of domain experience, and is advised by former senior Korean science ministry officials. REMEDI has been recognized with the South Korean government's K-Export Star 500 and Global Hidden Champion 1000+ designations and the Five Million Dollar Export Tower award, and is preparing for a KOSDAQ IPO scheduled for July 13, 2026, priced at 20,700 KRW with an oversubscription ratio of 1,146:1. The firm employs between 51 and 100 people and is headquartered in South Korea.
REMEDI firmographics
Firmographics- Name
- REMEDI
- Legal name
- (주)레메디 (Remedi Inc.)
- Website
- https://remedihc.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- REMEDI is a South Korean medical device company that designs ultra-compact portable X-ray systems for point-of-care use, serving government health programs, defense agencies, and hospitals across 58 countries with 10,000+ units deployed.
- Ownership category
- akta.pro rank
REMEDI industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Dental Equipment & Supplies (3843)
- akta.pro primary industry
- Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)
- akta.pro secondary industry
- X-ray & Fluoroscopy Systems (HLAHABAA)
Keywords
Where REMEDI is headquartered
LocationHeadquarters
- HQ city
- Yongdungpo
- HQ country
- South Korea
- HQ region
- Asia
Offices5 records
Markets served
REMEDI business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Portable X-ray Device Sales: Sale of handheld/portable X-ray cameras (REMEX-KA6, XCam6, XCam10), dental X-ray cameras (T100, GR100), and related accessories including detectors and sensors
- After-sales Service: Three-year after-sales service provided with government contracts (e.g., India NTEP 1,534 units contract)
- Product Licensing: European market licensing of digital intraoral sensors (IoDS-2401, 2402), dental X-ray equipment (T100/K100), and technology licensing arrangements
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/Government Sales |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
REMEDI product offering
Product offeringCore offering
REMEDI develops and manufactures ultra-compact, low-dose portable X-ray imaging systems based on its proprietary miniature thermionic X-ray tube and High Voltage Power Supply (HVPS) technology. The REMEX product family spans handheld medical X-ray cameras (KA6, XCam6), dental X-ray cameras (T100, GR100), an industrial NDT unit (RIX-B100), digital intraoral sensors, intraoral cameras, and flat panel detectors, sold to government health programs, hospitals, dental clinics, and industrial customers across 58 countries.
Product overview
REMEDI develops and manufactures ultra-compact, low-dose portable X-ray imaging solutions for medical, dental, veterinary, and industrial applications. The product portfolio centers on lightweight handheld X-ray cameras (REMEX-KA6, REMEX-XCam6, REMEX-XCam10 for medical; REMEX-T100/K100, REMEX-GR100 for dental), complemented by digital intraoral sensors (IoDS-2401/2402), intraoral cameras (RIC-05MBA), flat panel detectors (RD1417/1717/1417F), and industrial NDT X-ray systems (RIX-B100). The ecosystem is unified around miniaturized X-ray tube technology and the proprietary Rena'ssant AI platform for diagnostic data analysis. Products serve point-of-care settings including TB screening, emergency response, space missions, and traditional healthcare environments.
Differentiator
Problem solved
Functional benefit
Brands
- REMEX: Product line brand for portable X-ray cameras including KA6, XCam6, XCam10, T100, GR100 models for medical, dental, and industrial applications
- Rena'ssant
- QuickRay
Products and services
- REMEX-KA6 Portable handheld X-ray camera for medical imaging with 40-70 kV tube voltage, 2-6 mA tube current, 0.4 mm focal spot, 2.4 kg weight, and DC 22.2V/1800 mAh battery power. Capable of imaging adult chest, pelvis, hands, feet, and head. Designed for point-of-care testing in ICU, OR, emergency response, primary care, nursing homes, and field diagnostics, including India's National Tuberculosis Elimination Program.
- REMEX-XCam6 Second-generation lightweight portable X-ray camera for medical imaging with 80/90 kV variable tube voltage, 6/5 mA variable tube current, 0.4 mm focal spot, 2.6 kg weight, and image acquisition under 3 seconds. Designed for superior image quality with low radiation exposure, with remote-control capability. NASA-selected for astronaut diagnostics and spacecraft inspection aboard SpaceX crewed spacecraft.
- REMEX-T100 (K100) Portable handheld X-ray camera for dental imaging in camera-type form factor, with 70 kV fixed tube voltage, 2 mA fixed tube current, 0.4 mm focal spot, and 1.9 kg weight. Point-and-shoot capability for convenient dental imaging. Targeted at general dentists, orthodontists, and dental clinics needing intraoral imaging.
- REMEX-GR100 Portable handheld X-ray camera for dental imaging in gun-type form factor, with 60/70 kV fixed tube voltage, 2.5/2 mA fixed tube current, 0.3 mm focal spot (smallest in the product line), and 1.5 kg weight. Features wireless charging and a cordless design for convenient dental procedures.
- IoDS-2401 / IoDS-2402 (QuickRay) Digital Intraoral Sensors Digital intraoral image sensors sold under the QuickRay brand. IoDS-2401 offers 39x25 mm outer dimensions, 30x20 mm image size, 20 μm pixel pitch, and 1.5 megapixel resolution; IoDS-2402 offers 42x30 mm outer dimensions, 34x26 mm image size, and 2.2 megapixel resolution. Both use CMOS sensors with CsI scintillator, rounded corners for patient comfort, and TWAIN driver connectivity for integration with dental imaging software. Targeted at dental clinics and imaging centers.
- RIC-05MBA Intraoral Camera
- RD1417 / RD1717 / RD1417F Flat Panel Detectors
- RIX-B100 Industrial X-ray (NDT)
- High Voltage Mini X-ray Generator (RMT-08) Well-optimized, CE-certified high voltage mini X-ray generator (RMT-08) sold as a replacement for existing X-ray generator modules and as the core component enabling the miniaturization of X-ray imaging devices for dentistry, medicine, and industrial inspection. Targeted at OEM manufacturers and integrators of X-ray imaging systems.
- After-Sales Service (Three-Year Service Contracts)
- European Market Technology Licensing
Quantifiable outcome
- 1/3 radiation dose compared to traditional equipment (Japan approval data)
- +4 more outcomes
Companies that use REMEDI
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
REMEDI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature5 records
REMEDI partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and strategic.
- Data4LifecoreMOU for global TB data platform construction and joint clinical research. Collaboration to advance AI-powered diagnostic research using REMEDI's proprietary 'Rena'ssant' platform and conduct WHO-standard clinical studies based on TB medical data.
- Indonesian Association of Hospital Engineering (IAHE)coreMOU for healthcare cooperation in Indonesia including TB screening projects and AI-powered portable X-ray system expansion. Both parties will explore future local production opportunities.
- POSCO InternationalcoreCooperation agreement for tuberculosis screening project in Indonesia and global market expansion. Partnership combines REMEDI's ultra-compact X-ray technology with POSCO International's global network to expand across emerging and developed markets.
- JLKstrategicCollaboration for lung diagnostic solution package combining REMEDI's portable X-ray with JLK's AI capabilities, strengthening platform competitiveness.
- NASA Glenn Research Centercore18-month evaluation leading to Xcam6 selection for NASA Mini X-ray Technology Demonstration project. Testing for imaging accuracy, non-destructive inspection capabilities, and durability for space missions.
- Korean National Tuberculosis Association (KNTA)corePartnership with KNTA Seoul Metropolitan Branch to improve TB and lung disease screening for vulnerable populations. X-ray systems deployed for data-based analysis and enhanced diagnostic accuracy.
- Public Procurement Service (PPS) - Overseas Demonstration SupportstrategicPPS overseas demonstration support program enabling portable X-ray demonstrations in India, leading to NASA success and 1,534-unit supply contract.
- NASAcoreNASA purchased REMEDI's self-developed portable X-ray device. Device recognized for low radiation, lightweight, and mobility features for space and specialized settings applications.
Scale indicators7 records
Recent moves9 records
Expansion highlights5 records
REMEDI competitors and assessment
Company assessmentDirect peers
- Nanox: Nanox develops digital X-ray source technology and is a direct competitor in next-generation, low-cost, portable X-ray imaging. It is also a strategic investor in REMEDI (2022), making it the closest comparable in technology, target market, and business model.
- MinXray: MinXray manufactures portable and handheld X-ray equipment for medical, veterinary, and military applications, directly overlapping with REMEDI's REMEX series in target customers (TB screening, field diagnostics, mobile clinics) and form factor.
- Micro-X: Micro-X (ASX:MX1) develops ultra-lightweight, mobile X-ray imaging systems using carbon nanotube technology, directly comparable to REMEDI's miniature thermionic tube approach and target use cases in emergency, military, and bedside imaging.
Emerging players
- KA Imaging: KA Imaging is a Canadian developer of portable and dual-energy X-ray detectors/systems, with overlap in portable medical X-ray and NDT segments relevant to REMEDI's KA6 and RIX-B100 product lines.
- Carestream Health: Carestream Health specializes in medical imaging including portable/compact digital X-ray systems and dental imaging, overlapping with REMEDI's portable and dental product lines and serving similar hospital and clinic customers.
Broad incumbents
- GE HealthCare: GE HealthCare is a dominant incumbent in medical imaging including portable and fixed X-ray systems. While it operates across modalities, its installed-base relationships and integrated PACS offerings represent the primary competitive threat in hospital channels.
- Philips: Philips Healthcare offers a broad portfolio including mobile X-ray systems (e.g., Mobilett) and enterprise imaging IT. It competes with REMEDI in hospital/ICU point-of-care imaging and has substantially larger R&D and channel resources.
- Siemens Healthineers: Siemens Healthineers provides a wide range of X-ray systems, including mobile solutions, and competes with REMEDI in both developed-market hospitals and emerging-market public health tenders.
- Fujifilm Healthcare: Fujifilm's healthcare division offers portable X-ray systems (FDR Visionary, FDR Go PLUS) and digital radiography solutions, directly competing with REMEDI in mobile imaging and dental sensor categories.
- Canon Medical Systems: Canon Medical Systems manufactures diagnostic X-ray systems including mobile/portable units. As a broad incumbent with global distribution, it competes with REMEDI across hospital and emerging-market channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
REMEDI social profiles
Digital presenceREMEDI compliance and trust
Trust signalCompliance13 records
REMEDI financial estimates
Financial estimateRevenue estimate
Valuation estimate
REMEDI leadership team
Management profileNumber of profiles
Profiles6 records
REMEDI subsidiaries and ownership
Company hierarchySubsidiaries2 records
REMEDI funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
REMEDI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about REMEDI
What does REMEDI do?
REMEDI develops and manufactures ultra-compact, low-dose portable X-ray imaging systems based on its proprietary miniature thermionic X-ray tube and High Voltage Power Supply (HVPS) technology. The REMEX product family spans handheld medical X-ray cameras (KA6, XCam6), dental X-ray cameras (T100, GR100), an industrial NDT unit (RIX-B100), digital intraoral sensors, intraoral cameras, and flat panel detectors, sold to government health programs, hospitals, dental clinics, and industrial customers across 58 countries.
Is REMEDI a public or private company?
REMEDI is a private company. It is classified as venture growth investor backed and is currently operating.
When was REMEDI founded?
REMEDI was founded in 2012. It employs 11 to 50 people.
Where is REMEDI based?
REMEDI is headquartered in Yongdungpo, South Korea, in the Asia region.
How does REMEDI make money?
Three revenue lines are on record. Portable X-ray Device Sales are the primary driver. The others are after-sales Service and product Licensing.
Who are REMEDI's main competitors?
Direct peers on record are Nanox, MinXray and Micro-X. Emerging players are KA Imaging and Carestream Health. Broad incumbents are GE HealthCare, Philips, Siemens Healthineers, Fujifilm Healthcare and Canon Medical Systems.
Does REMEDI have an API?
No public API is recorded for REMEDI.
What industry is REMEDI in?
REMEDI's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems, with a secondary code of HLAHABAA, X-ray & Fluoroscopy Systems. Its NAICS code is 334517 and its SIC code is 3844.